Chapter 36 – Chemokine Receptors on Human Mast Cells

[1]  L. Cosmi,et al.  Limited expression of R5-tropic HIV- 1 in CCR5-positive type 1-polarized T cells explained by their ability to produce RANTES, MIP-1α, and MIP-1β , 2000 .

[2]  F. Annunziato,et al.  Tryptase-chymase double-positive human mast cells express the eotaxin receptor CCR3 and are attracted by CCR3-binding chemokines. , 1999, The American journal of pathology.

[3]  P. Gray,et al.  Macrophage-derived chemokine is localized to thymic medullary epithelial cells and is a chemoattractant for CD3+, CD4+, CD8low thymocytes , 1999 .

[4]  H. Ochi,et al.  T Helper Cell Type 2 Cytokine–Mediated Comitogenic Responses and Ccr3 Expression during Differentiation of Human Mast Cells in Vitro , 1999, The Journal of experimental medicine.

[5]  A. Mantovani,et al.  The chemokine system: redundancy for robust outputs. , 1999, Immunology today.

[6]  J. Mikovits,et al.  Mast cell migratory response to interleukin-8 is mediated through interaction with chemokine receptor CXCR2/Interleukin-8RB. , 1999, Blood.

[7]  M. Reale,et al.  Intramuscular injection of hrRANTES causes mast cell recruitment and increased transcription of histidine decarboxylase in mice: lack of effects in genetically mast cell‐deficient W/WV mice , 1998, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[8]  P. Allavena,et al.  The viral chemokine macrophage inflammatory protein-II is a selective Th2 chemoattractant. , 1998, Blood.

[9]  M. Felaco,et al.  Mast cell recruitment after subcutaneous injection of RANTES in the sole of the rat paw , 1998, British journal of haematology.

[10]  D. Friend,et al.  Generation of a novel stem cell factor-dependent mast cell progenitor. , 1998, Journal of immunology.

[11]  L. Cosmi,et al.  Enhanced HIV expression during Th2‐oriented responses explained by the opposite regulatory effect of IL‐4 and IFN‐γ on fusin/CXCR4 , 1998, European journal of immunology.

[12]  J. Gutiérrez-Ramos,et al.  Eotaxin Modulates Myelopoiesis and Mast Cell Development From Embryonic Hematopoietic Progenitors , 1998 .

[13]  D. Schadendorf,et al.  Expression and functional activity of the IL-8 receptor type CXCR1 and CXCR2 on human mast cells. , 1998, Journal of immunology.

[14]  J. Westwick,et al.  Chemokines and T lymphocytes: more than an attraction. , 1998, Immunity.

[15]  T. Standiford,et al.  Novel role of transmembrane SCF for mast cell activation and eotaxin production in mast cell-fibroblast interactions. , 1998, Journal of immunology.

[16]  M. Baggiolini.  Chemokines and leukocyte traffic , 1998, Nature.

[17]  Jason G. Cyster,et al.  A B-cell-homing chemokine made in lymphoid follicles activates Burkitt's lymphoma receptor-1 , 1998, Nature.

[18]  M. Baggiolini,et al.  B Cell–attracting Chemokine 1, a Human CXC Chemokine Expressed in Lymphoid Tissues, Selectively Attracts B Lymphocytes via BLR1/CXCR5 , 1998, The Journal of experimental medicine.

[19]  A. Luster,et al.  Chemokines--chemotactic cytokines that mediate inflammation. , 1998, The New England journal of medicine.

[20]  M. Baggiolini,et al.  CCR5 is characteristic of Th1 lymphocytes , 1998, Nature.

[21]  P. Allavena,et al.  Differential Expression of Chemokine Receptors and Chemotactic Responsiveness of Type 1 T Helper Cells (Th1s) and Th2s , 1998, The Journal of experimental medicine.

[22]  R. Bravo,et al.  Defects in Macrophage Recruitment and Host Defense in Mice Lacking the CCR2 Chemokine Receptor , 1997, The Journal of experimental medicine.

[23]  Robert V Farese,et al.  Impaired monocyte migration and reduced type 1 (Th1) cytokine responses in C-C chemokine receptor 2 knockout mice. , 1997, The Journal of clinical investigation.

[24]  C. Mackay,et al.  Functional expression of the eotaxin receptor CCR3 in T lymphocytes co-localizing with eosinophils , 1997, Current Biology.

[25]  Brian A. Hemmings,et al.  G-Protein-coupled Receptors and Fcγ-receptors Mediate Activation of Akt/Protein Kinase B in Human Phagocytes* , 1997, The Journal of Biological Chemistry.

[26]  K. Ley,et al.  Severe reduction in leukocyte adhesion and monocyte extravasation in mice deficient in CC chemokine receptor 2. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[27]  M. Baggiolini,et al.  Chemotactic activity on mononuclear cells in the cerebrospinal fluid of patients with viral meningitis is mediated by interferon‐γ inducible protein‐10 and monocyte chemotactic protein‐1 , 1997, European journal of immunology.

[28]  C. Mackay,et al.  Selective expression of the eotaxin receptor CCR3 by human T helper 2 cells. , 1997, Science.

[29]  C. Mackay,et al.  High expression of the chemokine receptor CCR3 in human blood basophils. Role in activation by eotaxin, MCP-4, and other chemokines. , 1997, The Journal of clinical investigation.

[30]  N. Copeland,et al.  TECK: a novel CC chemokine specifically expressed by thymic dendritic cells and potentially involved in T cell development. , 1997, Immunity.

[31]  J. Hoxie,et al.  The chemokine SDF‐1, stromal cell‐derived factor 1, attracts early stage B cell precursors via the chemokine receptor CXCR4 , 1997, European journal of immunology.

[32]  Y. Kitamura,et al.  Expression of mast-cell-specific proteases in tissues of mice studied by in situ hybridization. , 1997, The American journal of pathology.

[33]  M. Welle.  Development, significance, and heterogeneity of mast cells with particular regard to the mast cell‐specific proteases chymase and tryptase , 1997, Journal of leukocyte biology.

[34]  Q. Hamid,et al.  Human monocyte chemoattractant protein (MCP)-4 is a novel CC chemokine with activities on monocytes, eosinophils, and basophils induced in allergic and nonallergic inflammation that signals through the CC chemokine receptors (CCR)-2 and -3. , 1996, Journal of immunology.

[35]  E. Wolf,et al.  A Putative Chemokine Receptor, BLR1, Directs B Cell Migration to Defined Lymphoid Organs and Specific Anatomic Compartments of the Spleen , 1996, Cell.

[36]  Anthony S. Fauci,et al.  Host factors and the pathogenesis of HIV-induced disease , 1996, Nature.

[37]  J J Goedert,et al.  Genetic Restriction of HIV-1 Infection and Progression to AIDS by a Deletion Allele of the CKR5 Structural Gene , 1996, Science.

[38]  Bernhard Moser,et al.  The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1 , 1996, Nature.

[39]  J. Sodroski,et al.  The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry , 1996, Nature.

[40]  Marc Parmentier,et al.  Resistance to HIV-1 infection in Caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene , 1996, Nature.

[41]  S. Nishikawa,et al.  Defects of B-cell lymphopoiesis and bone-marrow myelopoiesis in mice lacking the CXC chemokine PBSF/SDF-1 , 1996, Nature.

[42]  Richard A Koup,et al.  Homozygous Defect in HIV-1 Coreceptor Accounts for Resistance of Some Multiply-Exposed Individuals to HIV-1 Infection , 1996, Cell.

[43]  M. Baggiolini,et al.  Interleukin-2 regulates CC chemokine receptor expression and chemotactic responsiveness in T lymphocytes , 1996, The Journal of experimental medicine.

[44]  C. Mackay,et al.  Molecular cloning and characterization of a human eotaxin receptor expressed selectively on eosinophils , 1996, The Journal of experimental medicine.

[45]  J. Demartino,et al.  Cloning, expression, and characterization of the human eosinophil eotaxin receptor , 1996, The Journal of experimental medicine.

[46]  L. Picker,et al.  Lymphocyte Homing and Homeostasis , 1996, Science.

[47]  P. Leder,et al.  Human eotaxin is a specific chemoattractant for eosinophil cells and provides a new mechanism to explain tissue eosinophilia , 1996, Nature Medicine.

[48]  C. Combadière,et al.  Molecular Cloning of Human Eotaxin, an Eosinophil-selective CC Chemokine, and Identification of a Specific Eosinophil Eotaxin Receptor, CC Chemokine Receptor 3 (*) , 1996, The Journal of Biological Chemistry.

[49]  E. Butcher,et al.  Role of Rho in Chemoattractant-Activated Leukocyte Adhesion Through Integrins , 1996, Science.

[50]  S. Arya,et al.  Identification of RANTES, MIP-1α, and MIP-1β as the Major HIV-Suppressive Factors Produced by CD8+ T Cells , 1995, Science.

[51]  Armen B. Shanafelt,et al.  The Functional Role of the ELR Motif in CXC Chemokine-mediated Angiogenesis (*) , 1995, The Journal of Biological Chemistry.

[52]  T. Zuberbier,et al.  Effect of CC chemokines on mediator release from human skin mast cells and basophils. , 1995, International archives of allergy and immunology.

[53]  P. Leder,et al.  Murine eotaxin: an eosinophil chemoattractant inducible in endothelial cells and in interleukin 4-induced tumor suppression. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[54]  G. Bokoch.  Chemoattractant signaling and leukocyte activation. , 1995, Blood.

[55]  D. Taub,et al.  Human Interferon-inducible Protein 10 Is a Potent Inhibitor of Angiogenesis in Vivo , 1995 .

[56]  G. Neufeld,et al.  Platelet Factor-4 Inhibits the Mitogenic Activity of VEGF121 and VEGF165 Using Several Concurrent Mechanisms (*) , 1995, The Journal of Biological Chemistry.

[57]  R. Strieter,et al.  Role of C‐X‐C chemokines as regulators of angiogenesis in lung cancer , 1995, Journal of leukocyte biology.

[58]  D. Taub,et al.  Bone marrow-derived murine mast cells migrate, but do not degranulate, in response to chemokines. , 1995, Journal of immunology.

[59]  P. Murphy,et al.  Human cytomegalovirus open reading frame US28 encodes a functional beta chemokine receptor. , 1994, The Journal of biological chemistry.

[60]  L. Schwartz,et al.  Human mast cell heterogeneity. , 1994, Allergy proceedings : the official journal of regional and state allergy societies.

[61]  R. Whyte,et al.  Inhibition of interleukin 8 attenuates angiogenesis in bronchogenic carcinoma , 1994, The Journal of experimental medicine.

[62]  H. Kikutani,et al.  Molecular cloning and structure of a pre-B-cell growth-stimulating factor. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[63]  T. Springer.  Traffic signals for lymphocyte recirculation and leukocyte emigration: The multistep paradigm , 1994, Cell.

[64]  P. Montravers,et al.  High levels of interleukin-8 in the blood and alveolar spaces of patients with pneumonia and adult respiratory distress syndrome , 1993, Infection and immunity.

[65]  P. Murphy,et al.  Molecular piracy of mammalian interleukin-8 receptor type B by herpesvirus saimiri. , 1993, The Journal of biological chemistry.

[66]  C. Chitnis,et al.  A receptor for the malarial parasite Plasmodium vivax: the erythrocyte chemokine receptor. , 1993, Science.

[67]  T. Schall,et al.  Identification of a promiscuous inflammatory peptide receptor on the surface of red blood cells. , 1993, The Journal of biological chemistry.

[68]  N. Weidner,et al.  Heterogeneity of mast cells at multiple body sites. Fluorescent determination of avidin binding and immunofluorescent determination of chymase, tryptase, and carboxypeptidase content. , 1993, Pathology, research and practice.

[69]  T. Schall,et al.  Molecular cloning, functional expression, and signaling characteristics of a C-C chemokine receptor , 1993, Cell.

[70]  J. Huntley.  Mast cells and basophils: a review of their heterogeneity and function. , 1992, Journal of comparative pathology.

[71]  G. Caughey.  The structure and airway biology of mast cell proteinases. , 1991, American journal of respiratory cell and molecular biology.

[72]  T. Mosmann,et al.  Interleukin 10: a novel stimulatory factor for mast cells and their progenitors , 1991, The Journal of experimental medicine.

[73]  A. Dvorak,et al.  Development of human mast cells in vitro. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[74]  R. Benyon.  The human skin mast cell , 1989, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[75]  Yukihiko Kitamura,et al.  Regulation of mast cell differentiation , 1989, BioEssays : news and reviews in molecular, cellular and developmental biology.

[76]  J. Kuratsu,et al.  Purification and amino acid analysis of two human glioma-derived monocyte chemoattractants , 1989, The Journal of experimental medicine.

[77]  A. Gottlieb,et al.  Detection of a gamma interferon-induced protein IP-10 in psoriatic plaques , 1988, The Journal of experimental medicine.

[78]  L. Schwartz,et al.  Evaluation of human peripheral blood leukocytes for mast cell tryptase. , 1987, Journal of immunology.

[79]  L. Schwartz,et al.  Two types of human mast cells that have distinct neutral protease compositions. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[80]  J. Folkman,et al.  How is blood vessel growth regulated in normal and neoplastic tissue? G.H.A. Clowes memorial Award lecture. , 1986, Cancer research.

[81]  Y. Kitamura,et al.  Mast-cell precursors in the skin of mouse embryos and their deficiency in embryos of Sl/Sld genotype. , 1985, Developmental biology.

[82]  J. Ihle,et al.  Biologic properties of homogeneous interleukin 3. I. Demonstration of WEHI-3 growth factor activity, mast cell growth factor activity, p cell-stimulating factor activity, colony-stimulating factor activity, and histamine-producing cell-stimulating factor activity. , 1983, Journal of immunology.

[83]  Y. Kitamura,et al.  Mast‐cell precursors in various haematopoietic colonies of mice produced in vivo and in vitro , 1983, British journal of haematology.

[84]  E. Schnipper,et al.  The presence of mast cell precursors in rat peripheral blood. , 1981, Blood.

[85]  S. Strobel,et al.  Human intestinal mucosal mast cells: evaluation of fixation and staining techniques. , 1981, Journal of clinical pathology.

[86]  J. Schrader.  In in vitro production and cloning of the P cell, a bone marrow-derived null cell that expresses H-2 and Ia-antigens, has mast cell-like granules, and is regulated by a factor released by activated T cells. , 1981, Journal of immunology.

[87]  F. Burnet.  The probable relationship of some or all mast cells to the T-cell system. , 1977, Cellular immunology.

[88]  P. Allavena,et al.  Chemokines and chemokine receptors during activation and deactivation of monocytes and dendritic cells and in amplification of Th1 versus Th2 responses , 1998, International journal of clinical & laboratory research.

[89]  B Dewald,et al.  Human chemokines: an update. , 1997, Annual review of immunology.

[90]  B. Dewald,et al.  Interleukin-8 and related chemotactic cytokines--CXC and CC chemokines. , 1994, Advances in immunology.

[91]  P. Murphy.  The molecular biology of leukocyte chemoattractant receptors. , 1994, Annual review of immunology.

[92]  K. Norrby,et al.  Mast-cell-mediated angiogenesis: a novel experimental model using the rat mesentery , 1986, Virchows Archiv. B, Cell pathology including molecular pathology.

[93]  K. Kalveram,et al.  Evidence that tissue mast cells derive from mononuclear phagocytes. , 1982, International archives of allergy and applied immunology.

[94]  Y. Kitamura,et al.  Local development of mast cells from bone marrow-derived precursors in the skin of mice. , 1979, Blood.